185 related articles for article (PubMed ID: 33372609)
1. Development and validation of a VHL-associated immune prognostic signature for clear cell renal cell carcinoma.
Zhang J; Yan A; Cao W; Shi H; Cao K; Liu X
Cancer Cell Int; 2020 Dec; 20(1):584. PubMed ID: 33372609
[TBL] [Abstract][Full Text] [Related]
2. A DNA Damage Repair Gene Signature Associated With Immunotherapy Response and Clinical Prognosis in Clear Cell Renal Cell Carcinoma.
Peng L; Liang J; Wang Q; Chen G
Front Genet; 2022; 13():798846. PubMed ID: 35656315
[No Abstract] [Full Text] [Related]
3. Construction and Validation of an Autophagy-Related Prognostic Risk Signature for Survival Predicting in Clear Cell Renal Cell Carcinoma Patients.
Yang H; Han M; Li H
Front Oncol; 2020; 10():707. PubMed ID: 32432045
[No Abstract] [Full Text] [Related]
4. Exploration of the relationships between tumor mutation burden with immune infiltrates in clear cell renal cell carcinoma.
Zhang C; Li Z; Qi F; Hu X; Luo J
Ann Transl Med; 2019 Nov; 7(22):648. PubMed ID: 31930049
[TBL] [Abstract][Full Text] [Related]
5. Identification of a four immune-related genes signature based on an immunogenomic landscape analysis of clear cell renal cell carcinoma.
Gao X; Yang J; Chen Y
J Cell Physiol; 2020 Dec; 235(12):9834-9850. PubMed ID: 32452055
[TBL] [Abstract][Full Text] [Related]
6. Novel amino acid metabolism-related gene signature to predict prognosis in clear cell renal cell carcinoma.
Cheng X; Deng W; Zhang Z; Zeng Z; Liu Y; Zhou X; Zhang C; Wang G
Front Genet; 2022; 13():982162. PubMed ID: 36118874
[No Abstract] [Full Text] [Related]
7. Identification of a three-miRNA signature as a novel potential prognostic biomarker in patients with clear cell renal cell carcinoma.
Luo Y; Chen L; Wang G; Xiao Y; Ju L; Wang X
J Cell Biochem; 2019 Aug; 120(8):13751-13764. PubMed ID: 30957284
[TBL] [Abstract][Full Text] [Related]
8. Construction of a 13-Gene Signature as a Novel Prognostic Marker for Patients with Clear Cell Renal Cell Carcinoma and the Role of XCR1 in Cell Proliferation.
Yuan B; Li F; Li Y; Chen Y
Cancer Manag Res; 2020; 12():4017-4027. PubMed ID: 33116819
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of neutrophil extracellular trap signature in clear cell renal cell carcinoma.
Li R; Jiang X; Wang P; Liu X
Front Oncol; 2023; 13():1205713. PubMed ID: 37519809
[TBL] [Abstract][Full Text] [Related]
10. A New Prognostic Risk Signature of Eight Ferroptosis-Related Genes in the Clear Cell Renal Cell Carcinoma.
Chen J; Zhan Y; Zhang R; Chen B; Huang J; Li C; Zhang W; Wang Y; Gao Y; Zheng J; Li Y
Front Oncol; 2021; 11():700084. PubMed ID: 34249761
[TBL] [Abstract][Full Text] [Related]
11. A MUCINs expression signature impacts overall survival in patients with clear cell renal cell carcinoma.
Meng H; Jiang X; Huang H; Shen N; Guo C; Yu C; Yin G; Wang Y
Cancer Med; 2021 Sep; 10(17):5823-5838. PubMed ID: 34327857
[TBL] [Abstract][Full Text] [Related]
12. Development and Interpretation of a Genomic Instability Derived lncRNAs Based Risk Signature as a Predictor of Prognosis for Clear Cell Renal Cell Carcinoma Patients.
Yang H; Xiong X; Li H
Front Oncol; 2021; 11():678253. PubMed ID: 34094983
[TBL] [Abstract][Full Text] [Related]
13. Identification of a Novel Immune-Related Prognostic Biomarker and Small-Molecule Drugs in Clear Cell Renal Cell Carcinoma (ccRCC) by a Merged Microarray-Acquired Dataset and TCGA Database.
Xiao GF; Yan X; Chen Z; Zhang RJ; Liu TZ; Hu WL
Front Genet; 2020; 11():810. PubMed ID: 33014010
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of the clinical roles of the VHL-related LncRNAs in clear cell renal cell carcinoma.
Yang W; Zhou J; Zhang K; Li L; Xu Y; Ma K; Xie H; Cai L; Gong Y; Gong K
J Cancer; 2021; 12(9):2702-2714. PubMed ID: 33854630
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of Metabolism-Related Genes and Immune Infiltration in Clear Cell Renal Cell Carcinoma.
Li H; Mo Z
Int J Gen Med; 2021; 14():6885-6898. PubMed ID: 34703293
[TBL] [Abstract][Full Text] [Related]
16. Development and Validation of a Clinical Prognostic Model Based on Immune-Related Genes Expressed in Clear Cell Renal Cell Carcinoma.
Ren S; Wang W; Shen H; Zhang C; Hao H; Sun M; Wang Y; Zhang X; Lu B; Chen C; Wang Z
Front Oncol; 2020; 10():1496. PubMed ID: 32983989
[No Abstract] [Full Text] [Related]
17. A 20-Gene Signature Predicting Survival in Patients with Clear Cell Renal Cell Carcinoma Based on Basement Membrane.
Yin Z; Zhao Y; Zhou W; You C; Bai Y; You B; Lu D; Liao S; Zheng L; Sun Y; Wu Y
J Oncol; 2023; 2023():1302278. PubMed ID: 37089260
[TBL] [Abstract][Full Text] [Related]
18. Differentially Expressed Genes in Clear Cell Renal Cell Carcinoma as a Potential Marker for Prognostic and Immune Signatures.
Tong Y; Yu Y; Zheng H; Wang Y; Xie S; Chen C; Lu R; Guo L
Front Oncol; 2021; 11():776824. PubMed ID: 34976818
[TBL] [Abstract][Full Text] [Related]
19. Independent association of PD-L1 expression with noninactivated VHL clear cell renal cell carcinoma-A finding with therapeutic potential.
Kammerer-Jacquet SF; Crouzet L; Brunot A; Dagher J; Pladys A; Edeline J; Laguerre B; Peyronnet B; Mathieu R; Verhoest G; Patard JJ; Lespagnol A; Mosser J; Denis M; Messai Y; Gad-Lapiteau S; Chouaib S; Belaud-Rotureau MA; Bensalah K; Rioux-Leclercq N
Int J Cancer; 2017 Jan; 140(1):142-148. PubMed ID: 27623354
[TBL] [Abstract][Full Text] [Related]
20. Identification and validation of the molecular subtype and prognostic signature for clear cell renal cell carcinoma based on neutrophil extracellular traps.
Quan J; Huang B
Front Cell Dev Biol; 2022; 10():1021690. PubMed ID: 36523511
[No Abstract] [Full Text] [Related]
[Next] [New Search]
